Area of Research: Immunotherapy

2022 Grant Recipients

• Livnat Jerby, Stanford University
  Early Career Investigator Grant
  Targeting multifactorial immune evasion mechanisms in ovarian cancer
• Lindsay Brubaker, MD, University of Colorado - Denver
  Early Career Investigator Grant
  Targeting Chromobox 2 to Overcome Macrophage-induced Immune Suppression
• Sammy Ferri-Borgogno, PhD, MD Anderson Cancer Center
  Early Career Investigator Grant
  BRCA-deficient Ovarian Cancer and IFITM3: a New Power Couple
• Ronald Buckanovich, MD, PhD, Magee-Womens Research Institute
  Collaborative Research Development Grant
  Role of Macrophage-secreted BIGH3 in Tumor Immunity
• Zelei Yang, PhD, Dana Farber Cancer Institute
  Mentored Investigator Grant
  Re-engaging the Anti-tumor Immune Response Against Ovarian Cancer
• Erin Wesley, PhD, University of Minnesota Twin Cities
  Mentored Investigator Grant
  Impact of Cytomegalovirus and Inflammation on NK Cells in Ovarian Cancer
• Veethika Pandey, PhD, University of Pennsylvania
  Mentored Investigator Grant
  Overcoming T Cell Exhaustion in Ovarian Cancer Tumor Microenvironment
• Patrick Innamarato, PhD, Moffitt Cancer Center and Research Institute
  Mentored Investigator Grant
  Determination of the Immunogenic Antigen Repertoire in Ovarian Cancer
• Melica Brodeur, MD, Memorial Sloan Kettering Cancer Center
  Mentored Investigator Grant
  Exploiting SMARCA4 Alterations for New Therapeutics in Ovarian Cancers

2021 Grant Recipients

• Sammy Ferri-Borgogno, PhD, MD Anderson Cancer Center
  Mentored Investigator Grant
  Spatially-Resolved Cellular and Transcriptome Analyses of Ovarian Cancer
• Ichiko Kinjyo, MD, PhD, University of New Mexico
  Early Career Investigator Grant
  A Novel Mechanism for the Immunomodulatory Effects of PARP-inhibitor
• Sandra Cascio, PhD, Magee-Womens Research Institute
  Early Career Investigator Grant
  EGFL6 as a New Regulator of Myeloid Cell Expansion and Function in HGSOC
• Martin Cannon, PhD, University of Arkansas for Medical Sciences
  Collaborative Research Development Grant
  Understanding and Targeting Myeloid Populations in Ovarian Cancer

2020 Grant Recipients

• Yilun Deng, PhD, University of Texas Health Science Center at San Antonio
  Mentored Investigator Grant
  CD122-Selective IL-2 Complexes as Novel Ovarian Cancer Therapy
• Sudipto Ganguly, PhD, Johns Hopkins University
  Early Career Investigator Grant
  Characterizing a Novel Checkpoint Axis in High-Grade Serous Ovarian Cancer
• Duygu Ozmadenci, PhD, University of California - San Diego
  Mentored Investigator Grant
  Sensitizing Ovarian Cancer to Immunotherapies
• Elizabeth Raupach, PhD, The Translational Genomics Research Institute
  Mentored Investigator Grant
  Oncogenic Consequences of Altered SWI/SNF-RNA Interactions in SCCOHT
• Camilla Salvagno, PhD, Weill Medical College of Cornell University
  Mentored Investigator Grant
  Dissecting How ER Stress Responses Shape Ovarian Cancer Immuno-Environments
• Dmitriy Zamarin, MD, PhD, Memorial Sloan Kettering Cancer Center
  Early Career Investigator Grant
  Chromatin Remodeling and Immunotherapy in Ovarian Cancer

2019 Grant Recipients

• Sarah Gitto, PhD, University of Pennsylvania
  Mentored Investigator Grant
  Modeling Autologous TIL Therapy in Novel PARP Resistant PDX Model for Ovarian Cancer
• Jing Li, MD, PhD, University of Michigan
  Mentored Investigator Grant
  ARID1A Drives Ovarian Cancer Immunotherapy
• Elaine Stur, PhD, MD Anderson Cancer Center
  Mentored Investigator Grant
  Re-activating Anti-tumor Immunity Targeting PSEN1 in CAFS in Ovarian Cancer
• Min Soon Cho, PhD, MD Anderson Cancer Center
  Early Career Investigator Grant
  The Role of Platelet in the Regulation of Immune Response to Ovarian Cancer
• Takemasa Tsuji, PhD, Roswell Park Comprehensive Cancer Center
  Early Career Investigator Grant
  Utilization of Tumor-recognizing CD4+T Cells in Cancer Immunotherapy
• Ronald Buckanovich, MD, PhD, Magee-Womens Research Institute
  Collaborative Research Development Grant
  Targeting Tumor Desmoplasia to Enhance Immunotherapy

2018 Grant Recipients

• Marcela Haro, PhD, Cedars-Sinai Medical Center
  Mentored Investigator Grant
  Cancer Associated Fibroblasts Hinder the B Cell Anti-Tumor Response
• Ye Hu, MD, PhD, Cedars-Sinai Medical Center
  Mentored Investigator Grant
  Reciprocal Roles of CAFs and CD4+ T Cells in Cancer Progression
• Sarah Stuckelberger, MD, University of Pennsylvania
  Mentored Investigator Grant
  Development of A Novel Syngeneic Model System for Ovarian Cancer Research
• Chunsheng Li, PhD, University of Pennsylvania
  Early Career Investigator Grant
  Imaging Guided Immunotherapy Targeting CD248 for Epithelial Ovarian Cancer

2017 Grant Recipients

• Marion Curtis, PhD, University of Chicago
  Mentored Investigator Grant
  Mediators of Chemosensitivity and Immunotherapy Targets
• Tyler Curiel, MD, University of Texas Health Science Center at San Antonio
  Collaborative Research Development Grant
  Rational Design of Effective Multi-modal Ovarian Cancer Immunotherapy
• Michael Goldberg, PhD, Dana Farber Cancer Institute
  Early Career Investigator Grant
  Rational Immunity to Improve Survival Following Standard-of-care Chemo

2016 Grant Recipients

• Jessica Chacon, PhD, University of Pennsylvania
  Mentored Investigator Grant
  Investigating the Role of Immunosuppressive Molecules in Ovarian Cancer
• David Spriggs, MD, Memorial Sloan Kettering Cancer Center
  Collaborative Research Development Grant
  Novel Approaches to Immunotherapy
• Fan Zhao, PhD, Stanford University
  Mentored Investigator Grant
  Ovarian Cancer Antigen Discovery by Single t-cell Analysis and pHLA Library
• Alexandra Snyder Charen, MD, Memorial Sloan Kettering Cancer Center
  Early Career Investigator Grant
  Unmasking Ovarian Cancers to Induce Immune Control
• Sherry Wu, PhD, MD Anderson Cancer Center
  Early Career Investigator Grant
  Re-activating Anti-tumor Immunity Using Non-coding RNAs

2015 Grant Recipients

• Juan Cubillos-Ruiz, PhD, Weill Medical College of Cornell University
  Mentored Investigator Grant
  ER Stress Sensor XBP1 as a Key Regulator of Ovarian Cancer Immunity
• Alfredo Perales-Puchalt, MD, The Wistar Institute
  Mentored Investigator Grant
  Targeting FSH Receptor with Chimeric Antigen Receptor in Ovarian Cancer
• Oladapo Yeku, MD, PhD, Memorial Sloan Kettering Cancer Center
  Mentored Investigator Grant
  A Phase I Trial Using Chimeric Antigen Receptors in Ovarian Cancer Patients
• Sarah Adams, MD, University of New Mexico
  Early Career Investigator Grant
  A Combination Therapy for Hereditary Ovarian Cancer
• Takemasa Tsuji, PhD, Roswell Park Cancer Institute
  Early Career Investigator Grant
  Utilization of Tumor-recognizing CD4+T cells in Cancer Immunotherapy

2014 Grant Recipients

• Tyler Curiel, MD, University of Texas Health Science Center at San Antonio
  Collaborative Research Development Grant
  Rational Design of Effective Multi-modal Ovarian Cancer Immunotherapy
• Matthias Stephan, MD, PhD, Fred Hutchinson Cancer Research Center
  Early Career Investigator Grant
  In vivo Programming of Ovarian Tumor-reactive T-cells Using Nanoparticles

2013 Grant Recipients

• Michael Goldberg, PhD, Dana Farber Cancer Institute
  Early Career Investigator Grant
  siRNA Targeting Immunosuppressive and Oncogenic Pathways in Ovarian Cancer

2012 Grant Recipients

• George Coukos, M.D., Ph.D., University of Pennsylvania
  Collaborative Research Development Grant
  Engineering Immune Cells to Better Recognize and Kill Ovarian Cancer

2011 Grant Recipients

• Gregory Motz, PhD, University of Pennsylvania
  Mentored Investigator Grant
  Stimulating Immune Cells to Fight Ovarian Cancer
• Sarah Adams, MD, University of Pennsylvania
  Early Career Investigator Grant
  Development of Combination Therapy with PARP-Inhibitors and Immunomodulation for BRCA1-Epithelial Ovarian Cancer
• Bin Zhang, MD, PhD, University of Texas Health Science Center at San Antonio
  Early Career Investigator Grant
  Developing Ways to Enhance the Immune System’s Ability to Fight Ovarian Cancer

2008 Grant Recipients

• George Coukos, M.D., Ph.D., University of Pennsylvania
  Collaborative Research Development Grant
  Engineering T Cells to Augment Natural Immunity to Ovarian Cancer
• Jose Conejo-Garcia, MD, PhD, The Wistar Institute
  Early Career Investigator Grant
  Reprogramming Immune Cells to Treat Ovarian Cancer

2007 Grant Recipients

• Kunle Odunsi, MD, PhD, Roswell Park Cancer Institute
  Collaborative Research Development Grant
  Enhancing Immunity to Ovarian Cancer Tumors
• Jonathan S. Berek, MD, MMS, Stanford University
  Collaborative Research Development Grant
  Leading the Effort to Develop Vaccines and Immunotherapy for Ovarian Cancer

2005 Grant Recipients

• Jose Conejo-Garcia, MD, PhD, Dartmouth Medical School
  Early Career Investigator Grant
  Vascular Leukocytes as novel anti-tumor therapeutic targets

2004 Grant Recipients

• Anda Vlad, MD, PhD, University of Pittsburgh
  Individual Investigator Award
  Immunotherapy of Ovarian Cancer Using Certain Tumor Specific Glycopeptides
• Brian Barnett, MD, Tulane University Health Sciences Center
  Mentored Investigator Grant
  Depleting Regulatory T Cells to Treat Ovarian Cancer

2003 Grant Recipients

• Naomi Hunder, MD, Fred Hutchinson Cancer Research Center
  Mentored Investigator Grant
  Evaluation of Mesothelin as a Taret Antigen in Ovarian Cancer